TechnoPhage and SIMM signed a collaboration agreement, announced at AICEP Portugal Global, involving a collaboration in both pre-clinical and future clinical studies of TA101 for the treatment of Rheumatoid Arthritis to market TA101 in the People’s Republic of China.
